Initial Country Assessments for depo-subQ provera 104™ in the Uniject™ Injection System - PATH

These executive summaries reveal findings and recommendations from initial assessments conducted in Bangladesh, Ethiopia, Kenya, Malawi, Nigeria, Pakistan, Rwanda, and Senegal. These countries were evaluated in terms of service delivery, supply systems, and stakeholder perspectives with respect to the feasibility and appropriateness of introducing depo-subQ in Uniject.

Corporate author(s): PATH

Publication date: 2009

Available materials

English

Bangladesh Initial Country Assessment

63 KB PDF

Hard copies are not available.

Ethiopia Initial Country Assessment

60 KB PDF

Hard copies are not available.

Kenya Initial Country Assessment

49 KB PDF

Hard copies are not available.

Malawi Initial Country Assessment

51 KB PDF

Hard copies are not available.

Nigeria Initial Country Assessment

56 KB PDF

Hard copies are not available.

Pakistan Initial Country Assessment

59 KB PDF

Hard copies are not available.

Rwanda Initial Country Assessment

59 KB PDF

Hard copies are not available.

Senegal Initial Country Assessment

52 KB PDF

Hard copies are not available.

French

Senegal Initial Country Assessment [French]

56 KB PDF

Also known as: Sénégal, Mission d’Evaluation Initiale

Hard copies are not available.

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Region: Global

See also:

Reproductive health > Family planning

Health technologies > Woman-initiated protection

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA